Bengaluru-based deep-tech startup Algorithmic Biologics (AlgoBio) made waves at the Genomics India Conference 2024 in Greater Noida by unveiling their Tapestry platform for next-generation sequencing (NGS). AlgoBio, founded by Dr. Manoj Gopalkrishnan, a multi-disciplinary technologist and IIT Bombay professor, is at the forefront of leveraging advanced algorithms and AI to revolutionize molecular testing efficiency and scale.
Tapestry, in line with AlgoBio’s vision, aims to enable accurate and affordable large-scale molecular testing. The platform empowers genomics labs by significantly reducing sequencing costs, eliminating 60 to 90% of library preparation costs, which constitute 33 to 50% of the total sequencing costs. This breakthrough could pave the way for more accessible and cost-effective genomic testing.
To fuel their ambitious goals, AlgoBio announced securing $2.5 million in pre-series A funding, led by Bharat Innovation Fund (BIF) Ventures, with participation from existing investor Axilor Ventures. The funds will be utilized to bolster the product pipeline, expand the sales organization, and support international expansion efforts.
In a strategic move, AlgoBio has also joined forces with Dhiti Omics Technologies, a pioneer in molecular diagnostics services in India, to offer ‘Focused Exome Sequencing’ powered by Tapestry. This partnership strengthens AlgoBio’s position in the genomics landscape by combining their cutting-edge technology with the expertise of Dhiti Omics Technologies.
Reflecting on the transformative potential of AlgoBio’s innovations, the narrative emphasizes the significant cost reductions brought about by advancements like compressed sensing technology. While the first human genome sequencing in 2000 carried a staggering $2.7 billion price tag, recent developments are rapidly making NGS more affordable, holding immense promise for personalized medicine and improved healthcare, bringing genomic testing closer to routine checkups.